[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"neonatal-opioid-withdrawal\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:neonatal-opioid-withdrawal":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":4,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":32,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":5},"100638947","cerebral-physiology-of-nows-100638947",false,"NCT07610746","Cerebral Physiology of NOWS","Early Detection of Neonatal Opioid Withdrawal Syndrome Using a Novel Cerebral Monitor.","NIRS for NOWS","Inclusion Criteria:\n\nInfants with prenatal opioid exposure:\n\n* Term born or near-term born (\\> 36w) infants\n* Birth weight \\> 2 Kg\n* History of prenatal opioid exposure\n\nControl infants:\n\n* Term born or near-term born (\\> 36w) infants\n* Birth weight \\> 2 Kg\n\nMothers of infants with prenatal opioid exposure:\n\n* greater or equal to 19 years of age\n* Use of opioid substances during pregnancy - Defined as pregnant women who 1) are clinically diagnosed as having an opioid use disorder and are on methadone or buprenorphine maintenance program or 2) have a urine drug test positive for prescribed or illicit opioids\n\nMothers of control infants:\n\n* greater than or equal to 19 years of age\n\nExclusion Criteria:\n\nInfants with prenatal opioid exposure:\n\n* APGAR score at 5 min \\\u003C 7\n* Any major congenital malformations or genetic syndromes\n* Need for positive pressure ventilation in the delivery room\n\nControl infants:\n\n* APGAR score at 5 min \\\u003C 7\n* Any major congenital malformations or genetic syndromes\n* Need for positive pressure ventilation in the delivery room\n* Any history of prenatal opioid exposure\n\nMothers of infants with prenatal opioid exposure:\n\n* Major maternal illness during pregnancy or delivery that could impact infant cerebral perfusion as deemed by the study investigators (e.g. uterine rupture or preeclampsia)\n\nMothers of control infants:\n\n* Major maternal illness during pregnancy or delivery that could impact infant cerebral perfusion as deemed by the study investigators (e.g. uterine rupture or preeclampsia)\n* Tobacco, SSRI or any opioid use during pregnancy",true,"ALL","1 Day",{"count":21,"type":22},46,"ESTIMATED","INTERVENTIONAL",[25],"NA","This study will use a new device to measure blood flow and oxygen levels in the brains of newborn infants who have had exposure to opioid medications in the womb, compared to newborns who have not had any exposure.",[28,29,30,31],"Neonatal Opioid Withdrawal","Neonatal Opioid Withdrawal Syndrome","Opioid Use Disorder","Intrauterine Exposure",[33,34,35],"neonatal opioid withdrawal syndrome","near infrared spectroscopy","diffuse correlation spectroscopy","RECRUITING","2026-08-18",{"date":39,"type":40},"2026-08-19","ACTUAL",{"date":42,"type":40},"2026-08-11",{"date":44,"type":22},"2027-08",{"name":46,"class":47},"Indiana University","OTHER"]